Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"

doi:10.1161/ATVBAHA.121.316203

Comment

. 2021 Jun;41(6):e381-e382.

doi: 10.1161/ATVBAHA.121.316203. Epub 2021 May 26.

Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"

Nigel Mackman¹, Yohei Hisada¹, Steven P Grover¹, Axel Rosell², Sebastian Havervall², Fien von Meijenfeldt³, Katherina Aguilera², Ton Lisman³, Charlotte Thålin²

Affiliations

¹ UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill (N.M., Y.H., S.P.G).
² Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden (A.R., S.H., K.A., C.T.).
³ Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, the Netherlands (F.v.M., T.L.).

PMID: 34038165
DOI: 10.1161/ATVBAHA.121.316203

Comment

Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"

Nigel Mackman et al. Arterioscler Thromb Vasc Biol. 2021 Jun.

. 2021 Jun;41(6):e381-e382.

doi: 10.1161/ATVBAHA.121.316203. Epub 2021 May 26.

Authors

Nigel Mackman¹, Yohei Hisada¹, Steven P Grover¹, Axel Rosell², Sebastian Havervall², Fien von Meijenfeldt³, Katherina Aguilera², Ton Lisman³, Charlotte Thålin²

Affiliations

¹ UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill (N.M., Y.H., S.P.G).
² Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden (A.R., S.H., K.A., C.T.).
³ Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, the Netherlands (F.v.M., T.L.).

PMID: 34038165
DOI: 10.1161/ATVBAHA.121.316203

No abstract available

PubMed Disclaimer

Comment on

Letter by Brambilla et al Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report".
Brambilla M, Canzano P, Becchetti A, Tremoli E, Camera M. Brambilla M, et al. Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):e379-e380. doi: 10.1161/ATVBAHA.121.316188. Epub 2021 May 26. Arterioscler Thromb Vasc Biol. 2021. PMID: 34038167 No abstract available.

Cited by

Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
Mackman N, Grover SP, Antoniak S. Mackman N, et al. J Thromb Haemost. 2021 Nov;19(11):2652-2658. doi: 10.1111/jth.15509. Epub 2021 Sep 3. J Thromb Haemost. 2021. PMID: 34418279 Free PMC article. Review.
Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells.
Puhm F, Allaeys I, Lacasse E, Dubuc I, Galipeau Y, Zaid Y, Khalki L, Belleannée C, Durocher Y, Brisson AR, Wolberg AS, Langlois MA, Flamand L, Boilard E. Puhm F, et al. Blood Adv. 2022 Jun 28;6(12):3593-3605. doi: 10.1182/bloodadvances.2022007444. Blood Adv. 2022. PMID: 35443030 Free PMC article.
Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles.
Burrello J, Caporali E, Gauthier LG, Pianezzi E, Balbi C, Rigamonti E, Bolis S, Lazzarini E, Biemmi V, Burrello A, Frigerio R, Martinetti G, Fusi-Schmidhauser T, Vassalli G, Ferrari E, Moccetti T, Gori A, Cretich M, Melli G, Monticone S, Barile L. Burrello J, et al. Vascul Pharmacol. 2022 Aug;145:106999. doi: 10.1016/j.vph.2022.106999. Epub 2022 May 18. Vascul Pharmacol. 2022. PMID: 35597450 Free PMC article.
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19.
Campello E, Radu CM, Simion C, Spiezia L, Bulato C, Gavasso S, Tormene D, Perin N, Turatti G, Simioni P. Campello E, et al. Front Cell Dev Biol. 2022 Jan 17;9:770463. doi: 10.3389/fcell.2021.770463. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35111751 Free PMC article.
Platelet extracellular vesicles in COVID-19: Potential markers and makers.
Puhm F, Flamand L, Boilard E. Puhm F, et al. J Leukoc Biol. 2022 Jan;111(1):63-74. doi: 10.1002/JLB.3MIR0221-100R. Epub 2021 Nov 3. J Leukoc Biol. 2022. PMID: 34730839 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"

Affiliations

Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical